Expression of HDAC9 is associated with decreased ERα expression and reduced ERα-mediated transcriptional activity in MCF-7 cells, and HDAC9-overexpressing BC cells are less sensitive to anti-estrogens. Here, ESR1 is linked to breast cancer.